Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY: NVO )

87.97 +6.87 (+8.47%)
Official Closing Price Updated: 7:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,545,306
Open 89.97
Bid (Size) 87.85 (1)
Ask (Size) 87.90 (1)
Prev. Close 81.10
Today's Range 86.57 - 89.97
52wk Range 78.17 - 148.15
Shares Outstanding N/A
Dividend Yield 1.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NVO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
S&P 500 Slips From Intraday Highs As Investors Lock In Profits After A Strong Week
The S&P 500 ended lower on Friday after setting fresh intraday records earlier in the session, as investors took profits following a strong week. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities

Performance

YTD
+0.51%
+0.51%
1 Month
+0.37%
+0.37%
3 Month
-22.41%
-22.41%
6 Month
-30.58%
-30.58%
1 Year
-16.76%
-16.76%

More News

Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
From Faruqi & Faruqi LLP
Via GlobeNewswire
$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Decoding Novo Nordisk's Options Activity: What's the Big Picture?
Via Benzinga
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Via The Motley Fool
Why Eli Lilly Stock Topped the Market Today
Via The Motley Fool
Stocks Stall, Gold Nears Record Highs As Dollar Faces Worst Week Since July 2023: What's Driving Markets Friday?
Via Benzinga
Why Novo Nordisk Stock Jumped a Lucky 7.7% Today
Via The Motley Fool
Allurion Catapults 200% On Its Plans To Outdo Eli Lilly, Novo Nordisk
Via Investor's Business Daily
Is Novo Nordisk Stock a Buy?
Via The Motley Fool
Novo Nordisk Unusual Options Activity
Via Benzinga
Customers Bancorp, Twilio, Dana And Other Big Stocks Moving Higher On Friday
Via Benzinga
Novo Nordisk Stock Eyes Best Day In 17 Months On New Obesity Drug Trial Data: Retail Breathes Easy
Via Stocktwits
Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results
Via Investor's Business Daily
Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
Via Benzinga
3 Unstoppable Stocks to Buy That Wall Street Thinks Will Soar More Than 35%
Via The Motley Fool
Novo Nordisk Inks License Agreement For Sickle Cell Disease Candidate
Via Benzinga
Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
Via MarketBeat
Investors should take note of NYSE:NVO, a growth stock that remains attractively priced.
Via Chartmill
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Via Benzinga
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
Via The Motley Fool
5 Stocks to Buy Now for Big Returns in 2025
Via The Motley Fool
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.